Vanguard health care fund

Vanguard health care fund DEFAULT

The performance data shown in tables and graphs on this page is calculated in USD of the fund/index/average (as applicable), on a Bid To Bid / Nav to Nav basis, with gross dividends re-invested on ex-dividend date. Past performance is not necessarily a guide to future performance; unit prices may fall as well as rise.

All managed funds data located on FT.com is subject to the FT Terms & Conditions

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

All data shown on this page, unless noted otherwise is Data Source and Copyright: Morningstar, Inc. 2021
All Rights reserved

www.morningstar.com

© 2021 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

Pricing for ETFs is the latest price and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Sours: https://markets.ft.com/data/funds/tearsheet/summary?s=VGHCX

Vanguard Health Care still has a personnel edge over its competition, and its other strengths remain intact. Both of its share classes retain their Morningstar Analyst Ratings of Silver.

Jean Hynes became the CEO of subadvisor Wellington Management Company in June 2021, as expected, and she continues to serve as the sole manager of this strategy. Although Hynes' CEO role adds significant responsibilities to her work running this large healthcare portfolio, she has been spending a significant portion of her time on executive functions for years and shed other duties in anticipation of becoming CEO. Hynes' overall workload is reasonable, and she remains one of the most experienced and talented healthcare investors around. She also draws on Wellington’s seasoned and skilled healthcare team, including the four managers on Hartford Healthcare HGHAX (which is a Morningstar Medalist).

This strategy's process, which is distinctive and sound, hasn't changed. In particular, Hynes continues to look for innovative firms with differentiated products or services and attractive valuations relative to their growth prospects; she continues to allow stock selection to drive industry exposures; and she continues to pay ample attention to foreign stocks. Indeed, the strategy currently has a pretty hefty stake in the pharmaceuticals industry, a relatively modest potion in the healthcare equipment and supplies industry, and a 27.4% weighting in foreign healthcare stocks.

This strategy has posted disappointing returns over the short- and mid-term periods, partly because its foreign exposure has been burdensome as international healthcare stocks have gained much less than their U.S. counterparts. However, though foreign healthcare stocks have also underperformed since Hynes took the helm in January 2013 and since she joined the management team in June 2008, the strategy has posted good risk-adjusted returns over both periods. And both share classes have low expense ratios that provide the strategy with an advantage going forward.

For all these reasons, this strategy remains a superior choice for investors seeking geographically diverse healthcare exposure.

Sours: https://www.morningstar.com/funds/xnas/vghcx/quote
  1. Bisquick oven fried chicken
  2. Peterbilt 379 flasher relay location
  3. Free pets craigslist lakeland fl
  4. 2017 subaru wrx limited horsepower
  5. 1999 chevy tahoe speaker size
  • Total Return
  • Consistent Return
  • Preservation
  • Tax Efficiency
  • Expense

YTD1YR3YR5YR10YR

Fund11.9116.7513.2112.9015.42
Category9.0618.2415.3513.5315.15
S&P 50022.3933.5520.2918.4316.20
% Rank in Category3772807544
Quintile Rank24443

Fund Details

Fund Details

  • Category
    GL Health/Biotech

  • Portfolio Style
    GL Health/Biotech

  • Expense Ratio
    0.27%

  • Status
    Open

  • Initial Purchase Regular
    $50,000

  • Load Type
    None

  • Front End Load
    N/A

  • Back End Load
    N/A

Investment Policy

The Fund seeks capital appreciation by investing principally in the equity securities of companies in the health care industry.

Management Details

  • Manager Name/Start Year
    Jean M. Hynes(2008)

  • Inception Date
    11/12/01

  • Phone Number
    800-662-2739

No news for VGHAX in the past two years.
DATEINCOME
DISTRIBUTION
Capital Gains
Distribution
2020 $0.85 $6.45
2019 $1.07 $9.35
2018 $1.03 $6.40
2017 $0.92 $5.46
2016 $0.83 $5.87
2015 $1.16 $6.48
2014 $0.94 $10.73
2013 $1.04 $5.91
2012 $1.20 $0.93
2011 $0.98 $2.19
Sours: https://www.wsj.com/market-data/quotes/mutualfund/VGHAX
3 Funds You Can Hold Forever
CategoryGL Health/Biotech
Portfolio StyleGL Health/Biotech
Fund FamilyVANGUARD FDS
Fund StatusOpen
Fund InceptionMay 23, 1984
Manager

Jean M. Hynes

The Fund seeks capital appreciation by investing principally in the equity securities of companies in the health care industry.

Front loadN/A
Deferred loadN/A
Max. redemption fee0%
Total expense ratio0.32%
12 b-10.01%
Turnover18%
Alpha-0.05
Beta0.70
Standard deviation4.61
R. squared0.68
Standard (taxable)$3,000
IRAN/A
Fund ReturnCategory1Index (S&P 500)% rank in categoryQuintile rank
YTD11.87%9.06%22.39%40%2
1yr16.70%18.24%33.55%74%4
3yr213.16%15.35%20.29%83%5
5yr212.84%13.53%18.43%78%4
10yr215.36%15.15%16.20%47%3
  • 1GL Health/Biotechnology
  • 23, 5 and 10 Year Returns are Annualized

This browser is no longer supported at MarketWatch. For the best MarketWatch.com experience, please update to a modern browser.

ChromeSafariFirefoxEdge

Sours: https://www.marketwatch.com/investing/fund/vghcx

Care fund health vanguard

Running his finger over the fabric, the man finally grabbed the lapel and began to unhurriedly unfasten the buttons, enjoying the submissiveness of the trembling. Young woman. Throwing the hem of his blouse over the girl's shoulders, he stroked the small breasts with obvious pleasure and easily pinched the nipples. Masha fell into a daze, frightened and not knowing what to do.

The owner of the house took a step back, admired the half-naked girl, and calmly said: - Tell me something: well, let's say: about the Italian.

Vanguard Health Care ETF - VHT - Fund Review

Well. Liked. - asked Andrey, grinning contentedly. In response, there was a resounding slap in the face. - Never do that again.

You will also like:

I blushed. Then find out, one of the girls interrupted us. Take your shift. - Luda crap again. - shouted the dough-mongers.



5987 5988 5989 5990 5991